Niacin And Laropiprant Combo Shows No Benefits, Has Some Harmful Effects In Patients With Vascular Disease
A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented at the American College of Cardiology’s 62nd Annual Scientific Session. Detailed trial data is presented here for the first time…
See original here:
Niacin And Laropiprant Combo Shows No Benefits, Has Some Harmful Effects In Patients With Vascular Disease
March 12, 2013 · by · in Nutritional News · Tags: annual-scientific, anti, highly-anticipated, nutrition, oncalldiets, session-detailed, the-vitamin, therapy, trial-data, vitamin
